Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

AbbVie Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (149)
Cancellation by sponsor (70)
Australian Public Assessment Report (AusPAR) (21)
Prescription medicine registration (20)
Designation or determination (6)
Prescription medicine evaluation (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (20)
2023 (27)
2022 (14)
2021 (14)
2020 (20)
2019 (25)
2018 (14)
2017 (29)
2016 (5)
2015 (19)
2014 (29)
2013 (4)
2012 (4)
2011 (4)
2010 (7)
2009 (4)
2008 (4)
2007 (1)
2006 (4)
2005 (4)
2003 (3)
2002 (2)
2001 (4)
1999 (1)
1998 (1)
1997 (1)
1996 (1)
1994 (2)
1991 (5)

Results for "[search-keyword]"

Search

Sponsor content

272 result(s) found, displaying 151 to 160

TECHNIVIE paritaprevir/ritonavir/ombitasvir 75mg/50mg/12.5mg tablets fixed dose combination blister pack Cancelled under Section 30(1)(c) of the Act

31 July 2018

Cancellation by sponsor

Requested by Abbvie Pty Ltd
SYNAGIS palivizumab (rmc) powder for injection 50mg/0.5mL (reconstituted) per vial with diluent ampoule Cancelled under Section 30(1)(c) of the Act

25 July 2018

Cancellation by sponsor

Requested by Abbvie Pty Ltd
SYNAGIS palivizumab (rmc) powder for injection 100mg/mL (reconstituted) per vial with diluent ampoule Cancelled under Section 30(1)(c) of the Act

25 July 2018

Cancellation by sponsor

Requested by Abbvie Pty Ltd
Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use (252515)

3 August 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use.
OZURDEX dexamethasone 700 microgram Intravitreal implant (222392)

4 June 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OZURDEX dexamethasone 700 microgram Intravitreal implant.
LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection (222375)

12 May 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection.
Abbvie Pty Ltd - Lubricant, eye (235723)

1 April 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
Abbvie Pty Ltd - Lubricant, eye (235724)

1 April 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
Abbvie Pty Ltd - Lubricant, eye (235722)

1 April 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
Abbvie Pty Ltd - Lubricant, eye (235633)

30 March 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.

Pages

First page
Previous page
…
Page 12
Page 13
Page 14
Page 15
Current page 16
Page 17
Page 18
Page 19
Page 20
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.